Evidence map›Paper›PMID 36329517›Full record

ArticleParasites & vectors2022

Sequencing of hsp70 for discernment of species from the Leishmania (Viannia) guyanensis complex from endemic areas in Colombia.

Juliana Hoyos, Mariana Rosales-Chilama, Cielo León, Camila González, María Adelaida Gómez

Open access · goldAbstract read
In one paragraph

Article in Parasites & vectors, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Resequencing and De Novo Assembly ofPathogens (Basel, Switzerland) · 2026
    Article
  3. Review
  4. Article
  5. Novel duplex TaqMan-based quantitative PCR for rapid and accurate diagnosis ofCurrent research in parasitology & vector-borne diseases · 2024
    Article
  6. Article
  7. Pathogens, reservoirs, and vectors involved in the transmission of vector-borne and zoonotic diseases in a Colombian region.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

Juliana HoyosDepartamento de Ciencias Biológicas, Centro de Investigaciones en Microbiología Y Parasitología Tropical (CIMPAT), Universidad de los Andes, Bogota, D.C, Colombia.
Mariana Rosales-ChilamaCentro Internacional de Entrenamiento E Investigaciones Médicas (CIDEIM), Campus de la Universidad Icesi (Edificio O), Cali, Colombia.
Cielo LeónDepartamento de Ciencias Biológicas, Centro de Investigaciones en Microbiología Y Parasitología Tropical (CIMPAT), Universidad de los Andes, Bogota, D.C, Colombia.
Camila GonzálezDepartamento de Ciencias Biológicas, Centro de Investigaciones en Microbiología Y Parasitología Tropical (CIMPAT), Universidad de los Andes, Bogota, D.C, Colombia. c.gonzalez2592@uniandes.edu.co.
María Adelaida GómezCentro Internacional de Entrenamiento E Investigaciones Médicas (CIDEIM), Campus de la Universidad Icesi (Edificio O), Cali, Colombia. mgomez@cideim.org.co.
Centro Internacional de Entrenamiento e Investigaciones Medicas · COCorporación para Investigaciones Biológicas · COIcesi University · COUniversidad de Los Andes · CO

Funding

The Innate Immune Response As A Therapeutic Target For Cutaneous LeishmaniasisU19AI129910 · NIAID · CENTRO INTERNACIONAL (CIDEIM) · PI GORE SARAVIA, NANCY · 2017 to 2021
$2.8M
NIAID NIH HHS U19 AI129910Wellcome TrustWellcome Trust 107595/Z/15/Z
6 · The paper itself

Abstract

backgroundColombia is ranked very high among countries with the highest numbers of endemic Leishmania species (n = 9) causing human disease. Although much effort has been devoted to generating simple and specific tools for Leishmania species identification, challenges remain in the discrimination of species belonging to the Leishmania (Viannia) guyanensis complex: L. (V.) guyanensis and L. (V.) panamensis.

methodsA set of seven reference strains of species belonging to the L. (Leishmania) and L. (Viannia) subgenera, clinical strains from human cases of cutaneous leishmaniasis (CL; n = 26) and samples collected from sylvatic mammals and sand flies (n = 7) from endemic areas in Colombia were analyzed in this study. The heat-shock protein 70 gene (hsp70) was amplified by PCR from DNA extracted from logarithmic-phase promastigotes or tissue samples, and the PCR products were sequenced. Sequence alignment was performed against a set of previously published and curated sequences, and phylogenetic analysis based on the maximum-likelihood and Bayesian inference approaches was conducted. Haplotype diversity among strains and species of the L. (V.) guyanensis complex was explored using a median-joining network.

resultsSequencing of the hsp70 gene for L. (Viannia) spp. typing was comparable to species identification using isoenzyme electrophoresis or monoclonal antibodies. Complete species matching was found, except for one sylvatic sample with an identity yet unsolved. Among the L. (V.) panamensis clinical strains, two distinctive phylogenetic clusters were found to correlate with two different zymodemes: L. (V.) panamensis Z2.2 and Z2.3. Analysis of samples from sylvatic environments identified novel records of naturally infected wild mammal and sand fly species.

conclusionsOur results support the adequacy of hsp70 gene sequencing as a single-locus approach for discrimination of L. (Viannia) spp., as well as for exploring the genetic diversity within the L. (V.) guyanensis complex.

Indexed as

LeishmaniaLeishmania guyanensisPsychodidaeAnimalsBayes TheoremColombiaHSP70 Heat-Shock ProteinsHumansMammalsPhylogenyHSP70 Heat-Shock Proteinshsp70HumanLeishmania (Viannia)MammalianSand flyTyping

Identifiers

PMID36329517
PMCPMC9635106
OpenAlexW4308303584

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.